Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

2 years ago

Originally published in Alkermes September 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 27, 2023 / Our employees are…

Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023

2 years ago

In 2023, Cosmos Health concluded multiple acquisitions, including Cana Laboratories, the distribution network owned by Bikas GP, and ZipDoctor.These acquisitions…

BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors

2 years ago

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Raymond…

Blue Horizon Announces CSE Approval of Change of Business and Commencement Date of Trading

2 years ago

Toronto, Ontario--(Newsfile Corp. - December 27, 2023) - Blue Horizon Global Capital Corp. (CSE: SENS) (CSE: BHCC) (formerly Sensor Technologies…

BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement

2 years ago

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV)…

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

2 years ago

DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer…

Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

2 years ago

Company to retain economic interest in biotherapeutic asset while removing cash burn from development and commercialization costsREDWOOD CITY, Calif., Dec.…

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

2 years ago

NKGen’s SNK01 program continues to show positive progress with the FDA IND clearance in October 2023, and now the CTA…

Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

2 years ago

BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on…